Global Custom Market Research Reports Provider Company

phone

Savara Inc (SVRA) - Financial and Strategic SWOT Analysis Review

  • Published Date: 05 Jul 2018
  • Number of Pages: 41
  • Category: SWOT Analysis
  • Country: United States of America
Savara Inc (SVRA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description A detailed description of the companys operations and business divisions.
- Corporate strategy Analysts summarization of the companys business strategy.
- SWOT Analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.
- Company history Progression of key events associated with the company.
- Major products and services A list of major products, services and brands of the company.
- Key competitors A list of key competitors to the company.
- Key employees A list of the key executives of the company.
- Executive biographies A brief summary of the executives employment history.
- Key operational heads A list of personnel heading key departments/functions.
- Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Savara Inc (Savara) formerly Mast Therapeutics Inc is a clinical stage biopharmaceutical company, which develops therapies for the treatment of rare respiratory diseases, including cystic fibrosis (CF), and pulmonary alveolar proteinosis (PAP). The companys lead product candidates include Molgradex, an inhaled formulation of recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF) for the treatment of treatment of PAP; and AeroVanc, an inhaled formulation of vancomycin for the treatment of CF. Its development pipeline also includes Aironite, a sodium nitrite solution for intermittent inhalation for the treatment of heart failure. The company has subsidiaries in the US and Denmark. Savara is headquartered in Austin, Texas, the US.

Savara Inc Key Recent Developments

May 09,2018: Savara Reports First Quarter 2018 Financial Results and Provides Business Update
Mar 14,2018: Savara Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Business Update
Jan 04,2018: Savara Announces Appointment of Peter Ginsberg as Vice President of Business Development
Nov 08,2017: Savara Reports Third Quarter 2017 Financial Results and Provides Business Update
Aug 09,2017: Savara Reports Second Quarter 2017 Financial Results and Provides Business Update

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The companys core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company
Publisher Name : GlobalData


List of Tables 4
List of Figures 4
Section 1 - About the Company 5
Savara Inc - Key Facts 5
Savara Inc - Key Employees 6
Savara Inc - Key Employee Biographies 7
Savara Inc - Major Products and Services 8
Savara Inc - History 9
Savara Inc - Company Statement 10
Savara Inc - Locations And Subsidiaries 12
Head Office 12
Other Locations & Subsidiaries 12
Section 2 Company Analysis 13
Company Overview 13
Savara Inc - Business Description 14
R&D Overview 14
Savara Inc - SWOT Analysis 15
SWOT Analysis - Overview 15
Savara Inc - Strengths 15
Savara Inc - Weaknesses 16
Savara Inc - Opportunities 17
Savara Inc - Threats 18
Savara Inc - Key Competitors 19
Section 3 Company Financial Ratios 20
Financial Ratios - Capital Market Ratios 20
Financial Ratios - Annual Ratios 21
Performance Chart 23
Financial Performance 23
Financial Ratios - Interim Ratios 24
Financial Ratios - Ratio Charts 25
Section 4 Companys Lifesciences Financial Deals and Alliances 26
Savara Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 26
Savara Inc, Medical Equipment, Deals By Type, 2012 to YTD 2018 27
Savara Inc, Recent Deals Summary 28
Section 5 Companys Recent Developments 29
May 09, 2018: Savara Reports First Quarter 2018 Financial Results and Provides Business Update 29
Mar 14, 2018: Savara Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Business Update 31
Jan 04, 2018: Savara Announces Appointment of Peter Ginsberg as Vice President of Business Development 33
Nov 08, 2017: Savara Reports Third Quarter 2017 Financial Results and Provides Business Update 34
Aug 09, 2017: Savara Reports Second Quarter 2017 Financial Results and Provides Business Update 35
May 01, 2017: Savara Secures $15 Million Loan And Security Agreement With Silicon Valley Bank 36
Section 6 Appendix 37
Methodology 37
Ratio Definitions 37
About GlobalData 41
Contact Us 41
Disclaimer 41

List Of Tables

List of Tables
Savara Inc, Key Facts 5
Savara Inc, Key Employees 6
Savara Inc, Key Employee Biographies 7
Savara Inc, Major Products and Services 8
Savara Inc, History 9
Savara Inc, Subsidiaries 12
Savara Inc, Key Competitors 19
Savara Inc, Ratios based on current share price 20
Savara Inc, Annual Ratios 21
Savara Inc, Annual Ratios (Cont...1) 22
Savara Inc, Interim Ratios 24
Savara Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 26
Savara Inc, Medical Equipment, Deals By Type, 2012 to YTD 2018 27
Savara Inc, Recent Deals Summary 28
Currency Codes 37
Capital Market Ratios 37
Equity Ratios 38
Profitability Ratios 38
Cost Ratios 39
Liquidity Ratios 39
Leverage Ratios 40
Efficiency Ratios 40

List Of Figures

List of Figures
Savara Inc, Performance Chart (2013 - 2017) 23
Savara Inc, Ratio Charts 25
Savara Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 26
Savara Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 27

Royal Mail plc (RMG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled by

View Report

Leclanche SA (LECN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled by GlobalData

View Report

NEC Corp (6701) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled by GlobalData

View Report
There is no reviews available for this report

Select License Type

Delivery Details

Delivery Details : Electronic files (PDF) of market research reports will dispatched within 12 to 24 hours. (Mon-Fri IST)

Customized Report

If a particular report is not as per your requirement you can ‎choose "Customized Report". To visit click on -

Custom Research Reports